Tamar Hanfling
Child & Adolescent Psychiatry · Danbury, CTNPI 1073683280
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 25.9% of the total. Reporting peaked in 2019 at $1,727 and has fallen 95.1% since, to $84 in 2024.
Across 143 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$674
- Otsuka America Pharmaceutical, Inc.$233
- Takeda Pharmaceuticals U.S.A., Inc.$227
- Lundbeck LLC$192
- Sunovion Pharmaceuticals Inc.$173
- Tris Pharma Inc$154
- plus $951 from 18 others
What the payments were for
- Food & beverage$2,605100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 30 | $674 |
| Otsuka America Pharmaceutical, Inc. | 12 | $233 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $227 |
| Lundbeck LLC | 10 | $192 |
| Sunovion Pharmaceuticals Inc. | 14 | $173 |
| Tris Pharma Inc | 10 | $154 |
| Shire North American Group Inc | 8 | $147 |
| Neurocrine Biosciences, Inc. | 8 | $138 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| Avanir Pharmaceuticals, Inc. | 7 | $100 |
| Ironshore Pharmaceuticals Inc. | 5 | $88 |
| Jazz Pharmaceuticals Inc. | 3 | $50 |
| Merck | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Adlon Therapeutics L.p. | 3 | $44 |
| Johnson & Johnson | 2 | $40 |
| Corium, LLC | 1 | $27 |
| Eisai Inc. | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Rhodes Pharmaceuticals L.p. | 1 | $15 |
| Harmony Biosciences LLC | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$2,605 in reported general payments places this provider in the 85th percentile of 71 child & adolescent psychiatry providers in Connecticut.
See all child & adolescent psychiatry providers in Connecticut →
Other child & adolescent psychiatry in Danbury
- Daniel KelleherDanbury$10K
- Robert KhalilDanbury$4K
- Aura ArdonDanbury$3K
- Kathleen RiveraDanbury$319
- Steven SpectorPlantsville$278K
- Claudia CarbonariGlastonbury$12K
- Cornelia GalloWestport$7K
- Allan JacobsWest Hartford$5K
- Ammar TraboulsiNew London$3K
- Mirjana DomakondaHartford$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.